China's Growing Influence on U.S. Medicine

China is increasing its control over the global pharmaceutical supply chain through economic strategies. The U.S. faces challenges in maintaining its leadership in the biomedical sector. Experts suggest that regulatory reforms are necessary to address this issue. Investment in domestic production capabilities is also being considered. The situation highlights the need for strategic policy changes. Economic dependencies could affect national security and public health. A proactive approach is essential to safeguard the industry.

It impacts the security and stability of the U.S. healthcare system and biomedical sector.